Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Erin Buysman's publication output changed over time?
ScholarIQpublication output · 2009–2024
Output grew0% over the shown period — from 1 works in 2009 to 1 in 2024.
1
2
1
1
2
2
1
1
20092010201120122013201520222024
What are the most-cited papers on Erin Buysman?
ScholarIQmost cited works
Impact of Medication Adherence and Persistence on Clinical and Economic Outcomes in Patients with Type 2 Diabetes Treated with Liraglutide: A Retrospective Cohort Study
Erin Buysman, Fang Liu, Mette Hammer, J Langer
Advances in Therapy. 2015102 CitationsOPEN ACCESS
Clinical and economic benefits observed when follow-up triglyceride levels are less than 500 mg/dL in patients with severe hypertriglyceridemia
Jennifer Christian, Bhakti Arondekar, Erin Buysman, Susan Johnson, John D. Seeger, Terry A. Jacobson
Journal of clinical lipidology. 201278 Citations
Determining Triglyceride Reductions Needed for Clinical Impact in Severe Hypertriglyceridemia
Jennifer Christian, Bhakti Arondekar, Erin Buysman, Terry A. Jacobson, Rose Snipes, Ralph I. Horwitz
The American Journal of Medicine. 201376 Citations
Economic burden and healthcare utilization associated with castration-resistant prostate cancer in a commercial and Medicare Advantage US patient population
B. Alemayehu, Erin Buysman, David Parry, Laura Becker, Faith E. Nathan
Journal of Medical Economics. 201048 CitationsOPEN ACCESS
Treatment patterns and resource utilization and costs among patients with pulmonary arterial hypertension in the United States
Mallik Angalakuditi, E.T. Edgell, Anthony Beardsworth, Erin Buysman, Tim Bancroft
Journal of Medical Economics. 201045 Citations
Related on ScholarIQ
Optum (United States)
Institution
Impact of Medication Adherence and Persistence on Clinical and Economic Outcomes in Patients with Type 2 Diabetes Treated with Liraglutide: A Retrospective Cohort Study
Paper
Clinical and economic benefits observed when follow-up triglyceride levels are less than 500 mg/dL in patients with severe hypertriglyceridemia
Paper
Determining Triglyceride Reductions Needed for Clinical Impact in Severe Hypertriglyceridemia
Paper
Economic burden and healthcare utilization associated with castration-resistant prostate cancer in a commercial and Medicare Advantage US patient population
Paper
Treatment patterns and resource utilization and costs among patients with pulmonary arterial hypertension in the United States
Paper